Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study (Q46761553)
Jump to navigation
Jump to search
scientific article published in October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study |
scientific article published in October 2005 |
Statements
1 reference
Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study (English)
1 reference
1 reference
Martin Bornhäuser
1 reference
Christoph Huber
1 reference
Georg Hess
1 reference
Donald Bunjes
1 reference
Wolfgang Siegert
1 reference
Rainer Schwerdtfeger
1 reference
Georg Ledderose
1 reference
Barbara Wassmann
1 reference
Guido Kobbe
1 reference
Andrew J Ullmann
1 reference
Thomas Kindler
1 reference
Ulrike Haus
1 reference
Harald Gschaidmeier
1 reference
Thomas Fischer
1 reference
1 October 2005
1 reference
1 reference
23
1 reference
30
1 reference
7583-7593
1 reference
Identifiers
1 reference
1 reference